Sector: Life Sciences / Genetics

Location: Oxford, United Kingdom

Business Overview

  • Genetic analysis of new drug molecules for Big Pharma companies to identify genetic mutations that mimic effect of drugs on proteins
  • Allows early triage of drugs that likely won’t work or likely to cause side effects; at least doubles chance of early identification of drugs that likely will work or can tackle other diseases

Related Ventures



Sector: Proptech Location: Australia Business Overview Fractionalized property investment platform Global opportunity significantly expanding the addressable market for an asset class UX-centric development including next-generation AR

Find out more

Access Telehealth

Sector: Med Tech Location: Australia Business Overview Access Telehealth is a healthcare company that focuses on providing specialist services for rural patients, NDIS and aged care residents Its business model is diversified across in-person and telehealth consultations and allows patients to access these services, fully bulk billed Strong management team stewarded by leading Australian oncologist, […]

Find out more

Looking for a strategic growth partner?